Current role
Drug Manufacturers - General · Healthcare
Chief Accounting Officer
2023-03-01–present
Sandra Patterson
Chief Accounting Officer
Gilead Sciences, Inc. (GILD)Equibles does not estimate personal net worth.
Get an email with a short summary when Gilead Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get GILD alertsAbout Sandra Patterson
Sandra Patterson is recorded as Chief Accounting Officer at Gilead Sciences, Inc. (GILD) since March 1, 2023. Gilead Sciences, Inc. reported in an 8-K filed July 28, 2022 that Sandra Patterson was appointed Senior Vice President, Corporate Controller, and principal accounting officer, effective March 1, 2023. Gilead Sciences, Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Gilead Sciences, Inc. includes Daniel P. O’Day (CEO), Robin L. Washington (CFO), Diane E. Wilfong (Chief Accounting Officer) and 7 others.
“The Company has named Sandra Patterson, who currently serves as Vice President, Assistant Controller, to be the Company's Senior Vice President, Corporate Controller, and principal accounting officer, effective March 1, 2023.”
Affiliation history
-
Current
2023-03-01–present
Company network
Leadership on record at Gilead Sciences, Inc.
- Daniel P. O’Day CEO
- Robin L. Washington CFO
- Diane E. Wilfong Chief Accounting Officer
- Erin Burkhart Chief Accounting Officer
- Anthony Welters Board Member
- JEFFREY A. BLUESTONE Board Member
- Jacqueline K. Barton Board Member
- Javier J. Rodriguez Board Member
- SANDRA J. HORNING Board Member
- Ted W. Love, M.D. Board Member